Ladenburg Thalmann Financial Services Inc. decreased its holdings in shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) by 16.0% in the 3rd quarter, HoldingsChannel reports. The firm owned 72,720 shares of the pharmacy operator’s stock after selling 13,883 shares during the period. Ladenburg Thalmann Financial Services Inc.’s holdings in Walgreens Boots Alliance were worth $5,615,000 at the end of the most recent reporting period.

Other large investors have also bought and sold shares of the company. Hudock Capital Group LLC boosted its position in shares of Walgreens Boots Alliance by 0.5% during the 2nd quarter. Hudock Capital Group LLC now owns 1,306 shares of the pharmacy operator’s stock valued at $102,000 after purchasing an additional 6 shares in the last quarter. Westside Investment Management Inc. boosted its position in shares of Walgreens Boots Alliance by 10.4% during the 2nd quarter. Westside Investment Management Inc. now owns 1,325 shares of the pharmacy operator’s stock valued at $102,000 after purchasing an additional 125 shares in the last quarter. Zions Bancorporation boosted its position in shares of Walgreens Boots Alliance by 983.3% during the 3rd quarter. Zions Bancorporation now owns 1,365 shares of the pharmacy operator’s stock valued at $105,000 after purchasing an additional 1,239 shares in the last quarter. IHT Wealth Management LLC boosted its position in shares of Walgreens Boots Alliance by 46.3% during the 2nd quarter. IHT Wealth Management LLC now owns 6,946 shares of the pharmacy operator’s stock valued at $135,000 after purchasing an additional 2,199 shares in the last quarter. Finally, Bristlecone Advisors LLC bought a new position in shares of Walgreens Boots Alliance during the 3rd quarter valued at about $135,000. Institutional investors own 61.18% of the company’s stock.

A number of analysts have commented on WBA shares. Needham & Company LLC reaffirmed a “buy” rating and set a $94.00 price objective on shares of Walgreens Boots Alliance in a research note on Saturday, September 16th. Jefferies Group reaffirmed a “buy” rating and set a $95.00 price objective on shares of Walgreens Boots Alliance in a research note on Wednesday, September 20th. Mizuho set a $94.00 price objective on shares of Walgreens Boots Alliance and gave the company a “buy” rating in a research note on Tuesday, October 24th. Royal Bank of Canada reaffirmed a “buy” rating and set a $88.00 price objective on shares of Walgreens Boots Alliance in a research note on Wednesday, October 25th. Finally, Loop Capital set a $90.00 price objective on shares of Walgreens Boots Alliance and gave the company a “buy” rating in a research note on Thursday, October 26th. Nine research analysts have rated the stock with a hold rating, fifteen have assigned a buy rating and one has given a strong buy rating to the stock. Walgreens Boots Alliance currently has an average rating of “Buy” and an average target price of $86.15.

Shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) opened at $76.07 on Friday. The stock has a market cap of $75,340.00, a P/E ratio of 21.01, a PEG ratio of 1.29 and a beta of 1.22. The company has a quick ratio of 0.47, a current ratio of 0.96 and a debt-to-equity ratio of 0.48. Walgreens Boots Alliance Inc has a 52-week low of $63.82 and a 52-week high of $88.00.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings data on Thursday, January 4th. The pharmacy operator reported $1.28 earnings per share for the quarter, beating the consensus estimate of $1.27 by $0.01. The firm had revenue of $30.74 billion for the quarter, compared to analyst estimates of $30.39 billion. Walgreens Boots Alliance had a net margin of 3.19% and a return on equity of 19.15%. The company’s revenue for the quarter was up 7.9% on a year-over-year basis. During the same quarter last year, the firm earned $1.10 earnings per share. research analysts anticipate that Walgreens Boots Alliance Inc will post 5.59 EPS for the current fiscal year.

Walgreens Boots Alliance declared that its Board of Directors has authorized a stock repurchase plan on Wednesday, October 25th that allows the company to buyback $1.00 billion in outstanding shares. This buyback authorization allows the pharmacy operator to buy shares of its stock through open market purchases. Shares buyback plans are typically an indication that the company’s board believes its shares are undervalued.

In related news, Director William C. Foote sold 2,736 shares of the firm’s stock in a transaction that occurred on Thursday, November 2nd. The shares were sold at an average price of $67.37, for a total transaction of $184,324.32. Following the transaction, the director now owns 16,415 shares of the company’s stock, valued at $1,105,878.55. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, Director John Anthony Lederer acquired 20,000 shares of the business’s stock in a transaction that occurred on Thursday, October 26th. The shares were acquired at an average cost of $67.00 per share, for a total transaction of $1,340,000.00. Following the transaction, the director now owns 50,000 shares of the company’s stock, valued at approximately $3,350,000. The disclosure for this purchase can be found here. 14.80% of the stock is currently owned by company insiders.

WARNING: “Ladenburg Thalmann Financial Services Inc. Trims Stake in Walgreens Boots Alliance Inc (WBA)” was first reported by Watch List News and is the property of of Watch List News. If you are reading this article on another site, it was copied illegally and republished in violation of U.S. and international copyright laws. The correct version of this article can be viewed at https://www.watchlistnews.com/ladenburg-thalmann-financial-services-inc-trims-stake-in-walgreens-boots-alliance-inc-wba/1805468.html.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with Analyst Ratings Network's FREE daily email newsletter.